375 related articles for article (PubMed ID: 32597237)
21. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices.
Cakici M; Cetin M; Balli M; Akturk E; Dogan A; Oylumlu M; Abus S; Yildiz E; Sungur A; Celiker M
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):709-15. PubMed ID: 24806326
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction.
Şen Ö; Şen SB; Topuz AN; Topuz M
Biomark Med; 2021 Oct; 15(15):1357-1366. PubMed ID: 34533051
[No Abstract] [Full Text] [Related]
24. Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention.
Tian J; Liu Y; Liu Y; Song X; Zhang M; Xu F; Yuan F; Lyu S
Dis Markers; 2017; 2017():8458492. PubMed ID: 29379223
[TBL] [Abstract][Full Text] [Related]
25. The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction.
Yildiz A; Yuksel M; Oylumlu M; Polat N; Akyuz A; Acet H; Aydin M; Ülgen MS
Clin Appl Thromb Hemost; 2015 Apr; 21(3):223-8. PubMed ID: 24431380
[TBL] [Abstract][Full Text] [Related]
26. Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Tasar O; Karabay AK; Oduncu V; Kirma C
Coron Artery Dis; 2019 Jun; 30(4):270-276. PubMed ID: 31026233
[TBL] [Abstract][Full Text] [Related]
27. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.
Esenboğa K; Kurtul A; Yamantürk YY; Tan TS; Tutar DE
Acta Cardiol; 2022 Feb; 77(1):59-65. PubMed ID: 33612077
[TBL] [Abstract][Full Text] [Related]
28. CHA2DS2-VASc Score is a Predictor of No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention.
Ipek G; Onuk T; Karatas MB; Gungor B; Osken A; Keskin M; Oz A; Tanik O; Hayiroglu MI; Yaka HY; Ozturk R; Bolca O
Angiology; 2016 Oct; 67(9):840-5. PubMed ID: 26685178
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Çağdaş ÖS; Altıntaş B; Burak C; Tanboğa HI
Eur J Clin Invest; 2018 Jun; 48(6):e12928. PubMed ID: 29577260
[TBL] [Abstract][Full Text] [Related]
30. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.
Wang L; Huang S; Zhou Q; Dou L; Lin D
Clin Cardiol; 2024 Feb; 47(2):e24238. PubMed ID: 38400562
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
33. Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction.
Ren F; Mu N; Zhang X; Tan J; Li L; Zhang C; Dong M
Am J Med Sci; 2016 Sep; 352(3):261-6. PubMed ID: 27650230
[TBL] [Abstract][Full Text] [Related]
34. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
[TBL] [Abstract][Full Text] [Related]
35. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
[TBL] [Abstract][Full Text] [Related]
36. D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial Infarction.
Gong X; Lei X; Huang Z; Song Y; Wang Q; Qian J; Ge J
J Cardiovasc Transl Res; 2021 Aug; 14(4):728-734. PubMed ID: 32212039
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Admission Time Cell Blood Count (CBC) Parameters in Predicting Post-primary Percutaneous Coronary Intervention TIMI Frame Count in Patients with ST-segment Elevation Myocardial Infarction.
Vakili H; Khaheshi I; Sharifi A; Nickdoost N; Namazi MH; Safi M; Saadat H; Parsa SA; Akbarzadeh MA; Naderian M; Yousefi N; Shirazi M; Tabary M
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):191-197. PubMed ID: 32026789
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Nutritional Index as a Predictor of No-Reflow Occurrence in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
Safak O; Yildirim T; Emren V; Avci E; Argan O; Aktas Z; Yildirim SE; Akgun DE; Kisacik HL
Angiology; 2024 Aug; 75(7):689-695. PubMed ID: 37553838
[TBL] [Abstract][Full Text] [Related]
39. Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Kikuchi S; Tsukahara K; Ichikawa S; Abe T; Minamimoto Y; Kimura Y; Akiyama E; Nakayama N; Okada K; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
Circ J; 2020 May; 84(6):975-984. PubMed ID: 32188836
[TBL] [Abstract][Full Text] [Related]
40. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
